DWTX
Dogwood Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.29
−2.14%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+52.7%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jun 17, 2026 | De La Rosa Abel · director | A-Award | 16,800 | $1.50 |
| Jun 17, 2026 | Keefer David R · director | A-Award | 16,800 | $1.50 |
| Jun 17, 2026 | Whitley Richard James · director | A-Award | 16,800 | $1.50 |
| Jun 17, 2026 | Thomas John C · director | A-Award | 16,800 | $1.50 |
| Mar 6, 2026 | Duncan Gregory Scott · director, officer: CHIEF EXECUTIVE OFFICER | A-Award | 330,000 | $2.86 |
| Mar 6, 2026 | Gendreau Roger Michael · officer: CHIEF MEDICAL OFFICER | A-Award | 82,500 | $2.86 |
| Mar 6, 2026 | Walsh Angela · officer: Chief Financial Officer | A-Award | 82,500 | $2.86 |
| Mar 6, 2026 | Grosswald Ralph · officer: SVP OF OPERATIONS | A-Award | 82,500 | $2.86 |
| Dec 5, 2025 | Duncan Gregory Scott · director, officer: CHIEF EXECUTIVE OFFICER | A-Award | 460,000 | $6.14 |
| Dec 5, 2025 | Walsh Angela · officer: Chief Financial Officer | A-Award | 150,000 | $6.14 |
| Dec 5, 2025 | Grosswald Ralph · officer: SVP OF OPERATIONS | A-Award | 150,000 | $6.14 |
| Dec 5, 2025 | Gendreau Roger Michael · officer: CHIEF MEDICAL OFFICER | A-Award | 150,000 | $6.14 |
| Jul 1, 2025 | Gendreau Roger Michael · officer: CHIEF MEDICAL OFFICER | A-Award | 12,075 | $4.71 |
| Jul 1, 2025 | Keefer David R · director | A-Award | 2,362 | $4.71 |
| Jul 1, 2025 | Duncan Gregory Scott · director, officer: CHIEF EXECUTIVE OFFICER | A-Award | 40,000 | $4.71 |
| Jul 1, 2025 | Thomas John C · director | A-Award | 2,362 | $4.71 |
| Jul 1, 2025 | Grosswald Ralph · officer: SVP OF OPERATIONS | A-Award | 12,075 | $4.71 |
| Jul 1, 2025 | Whitley Richard James · director | A-Award | 2,362 | $4.71 |
| Jul 1, 2025 | De La Rosa Abel · director | A-Award | 2,362 | $4.71 |
| Jul 1, 2025 | Walsh Angela · officer: Chief Financial Officer | A-Award | 12,075 | $4.71 |
| Jun 23, 2025 | Keefer David R · director | A-Award | 210 | $4.80 |
| Jun 23, 2025 | Thomas John C · director | A-Award | 210 | $4.80 |
| Jun 23, 2025 | De La Rosa Abel · director | A-Award | 210 | $4.80 |
| Jun 23, 2025 | Whitley Richard James · director | A-Award | 210 | $4.80 |
| Mar 17, 2025 | CK Life Sciences Intl (Holdings) Inc · director, 10 percent owner, other: See Remarks | A-Award | 284 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 7Increased 3Reduced 0Sold out 14
| Filer | Action | Shares | Filed |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | New Position | 3,280,000 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 132,154 | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 79,434 | May 15, 2026 |
| VANGUARD FIDUCIARY TRUST CO | New Position | 62,736 | May 8, 2026 |
| NORTHERN TRUST CORP | New Position | 23,779 | May 14, 2026 |
| GOLDMAN SACHS GROUP INC | New Position | 14,598 | May 15, 2026 |
| MARSHALL WACE, LLP | Increased | 11,756 | May 15, 2026 |
| CITADEL ADVISORS LLC | New Position | 11,742 | Sep 2, 2026 |
| TOWER RESEARCH CAPITAL LLC (TRC) | New Position | 8,067 | May 15, 2026 |
| UBS GROUP AG | Increased | 7,085 | May 5, 2026 |
| ACTIVEST WEALTH MANAGEMENT | Unchanged | 120 | Apr 15, 2026 |
| BLACKROCK, INC. | Unchanged | 30 | May 13, 2026 |
| GROUP ONE TRADING, L.P. | Unchanged | 9 | May 13, 2026 |
| BNP PARIBAS ARBITRAGE, SNC | Unchanged | 2 | May 12, 2026 |
| MARSHALL WACE, LLP | Sold Out | 0 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jun 17, 2026